Researchers from the University of North Carolina at Chapel Hill and North Carolina State University are developing a “smart” skin patch that delivers heparin, an anticoagulant drug, as a patient’s body needs it.
At the moment, patients on heparin receive their medication through an injection. In the future, this new patch could deliver heparin in response to the body. It can, “sense activated thrombin and subsequently releases heparin to prevent coagulation in the blood,” according to the research’s abstract. The patch is still in its testing phase.
For a closer look at this research and how it was conducted, the full research article can be accessed here.